Clinical Trial Matcher

NCT05840484

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Recruiting · Not specified · M.D. Anderson Cancer Center · registry updated 2026-08-10

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

Prostate cancer is the most commonly diagnosed cancer in men. However, there is a wide range in prognosis determined by a host of factors. This study will evaluate the feasibility of guiding therapeutic intervention electronically facilitated symptom and disease monitoring in patients being followed on Active Surveillance. Additionally, we will develop a tissue and data resource to support discovery and hypothesis generation to evaluate germline and/or somatic alterations in relation to cancer-specific and overall outcomes..

Inclusion

  • Patients will have histologic diagnosis of adenocarcinoma of the prostate within 24 months of study entry.
  • Patient must meet at least one of the following clinical indications for AS: National Comprehensive Cancer Network (NCCN) very low risk or low risk prostate cancer meeting consensus guidelines for AS; NCCN intermediate-risk prostate cancer requesting AS (per patient and clinician shared decision making); or have severe medical comorbidities (defined as CCI estimated 10-year survival \< 50% and agreed by treating clinician) with high- or very high-risk localized prostate cancer.
  • Patients must agree to comply with the surveillance schedule.
  • Patients must be over 18 years of age
  • Written informed consent
  • Patients must be fluent in the English language to participate in the patient report outcome and symptoms monitoring portion of the trial.

Exclusion

  • Patients are ineligible if they choose not to share their medical data for research purposes.
  • Prior radiation therapy for treatment of the primary tumor.
  • Planned concomitant hormonal therapy, chemotherapy, or radiation therapy while on protocol

Open NCT05840484 on ClinicalTrials.govAll conditions

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance | Clinical Trial Matcher